Our clients
Accelerate your antibody discovery research, enhance precision, and secure your innovations with Isogenica’s tailor-made solutions.
Unmatched diversity
Accelerate your antibody discovery research with access to the world’s largest synthetic VHH libraries
Working with us
Risk reduction for long-term success

Discovery Terms: Clear, Collaborative, and Built for Scientists
Panning & Screening
Characterisation & Evaluation
Final Deliverables & Licensing
You will receive an exclusive license to the five Selected Antibodies. This license grants you full rights to develop, optimise, patent, publish, and commercialise each candidate. While these antibodies remain physically present in Isogenica’s libraries, they are digitally withdrawn and will not be shared or licensed to any other party, including internally at Isogenica.
Our commercial model is Fee-for-Service. No milestones, royalties, or success fees apply.
Start your discovery with us
We tailor our approach to fit your unique project. Options include fee-for-service contracts, rolling FTE models, or success-based milestones. Each client’s needs determine the best model for collaboration.
Clients and case studies





